Pharmaceutical giant Adcock Ingram has confirmed its delisting from the Johannesburg Stock Exchange (JSE) on 11 November 2025. The move marks the end of its 17-year run as a public company. This follows the finalisation of a R4.2 billion acquisition scheme by the...
Health group Ascendis Health plans a significant change. The company will delist from the Johannesburg Stock Exchange (JSE). It has made a conditional offer to its investors. Ascendis will repurchase shares from them. The market reacted very positively to this news....
Pharmaceutical giant Adcock Ingram has announced flat annual profits despite a significant recovery in the second half of its financial year. This was buoyed by strong demand for its popular over-the-counter winter medicines. In a landmark move, the maker of household...
